Literature DB >> 35343231

Nanomaterials: The New Antimicrobial Magic Bullet.

John Ndayishimiye1,2, Tushar Kumeria3,4, Amirali Popat1,5, James Robert Falconer1, Mark A T Blaskovich2.   

Abstract

Bacterial infections are a significant cause of mortality and morbidity worldwide, despite decades of use of numerous existing antibiotics and constant efforts by researchers to discover new antibiotics. The emergence of infections associated with antibiotic-resistant bacterial strains, has amplified the pressure to develop additional bactericidal therapies or new unorthodox approaches that can deal with antimicrobial resistance. Nanomaterial-based strategies, particularly those that do not rely on conventional small-molecule antibiotics, offer promise in part due to their ability to dodge existing mechanisms used by drug-resistant bacteria. Therefore, the use of nanomaterial-based formulations has attracted attention in the field of antibiotic therapy. In this Review, we highlight novel and emerging nanomaterial-based formulations along with details about the mechanisms by which nanoparticles can target bacterial infections and antimicrobial resistance. A detailed discussion about types and the activities of nanoparticles is presented, along with how they can be used as either delivery systems or as inherent antimicrobials, or a combination of both. Lastly, we highlight some toxicological concerns for the use of nanoparticles in antibiotic therapies.

Entities:  

Keywords:  MRSA; antibiotic alternatives; antimicrobial resistance; nanomaterials

Mesh:

Substances:

Year:  2022        PMID: 35343231     DOI: 10.1021/acsinfecdis.1c00660

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  2 in total

Review 1.  Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.

Authors:  Nayanika Chakraborty; Diksha Jha; Indrajit Roy; Pradeep Kumar; Shailendra Singh Gaurav; Kalisvar Marimuthu; Oon-Tek Ng; Rajamani Lakshminarayanan; Navin Kumar Verma; Hemant K Gautam
Journal:  J Nanobiotechnology       Date:  2022-08-12       Impact factor: 9.429

Review 2.  Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies.

Authors:  Valentina Del Genio; Rosa Bellavita; Annarita Falanga; Katel Hervé-Aubert; Igor Chourpa; Stefania Galdiero
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.